Join
Live feed
·
INSIDERFilingvia Quantisnow
Apimeds Pharmaceuticals US Inc. logo

Director Koo Jakap bought $56,715 worth of shares (28,500 units at $1.99), increasing direct ownership by 5% to 643,885 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
APUS· Apimeds Pharmaceuticals US Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APUS (Apimeds Pharmaceuticals US Inc.) and more on Quantisnow.